Chaoju Eye Care preparing to re-enter acquisition mode?
The private hospital and clinic operator announced two new purchases, signaling a potential return to acquisitions after a quiet period last year Key Takeaways: Chaoju Eye Care announced plans to…
Medtide launches IPO to bulk up its weight-loss business
The pharmaceutical services firm wants to expand production of peptides used in anti-obesity drugs, but it faces fierce competition and other business risks Key Takeaways: The global market for developing…
So-Young rethinks reverse share split as its stock surges
The cosmetic surgery specialist’s shares have nearly doubled in the last two weeks as investors flock to its new business model centered on self-operated clinics Key Takeaways: So-Young has delayed…
Alphamab stake sale could signal harder times ahead
The founder of the cancer drug developer has cashed out part of his holdings after the stock hit a price peak, raising questions about the firm’s earnings outlook Key Takeaways:…
CSPC Pharma teases big bucks deals after earnings miss
The Chinese drug giant revealed it was in talks with three parties to license its products for up to $5 billion in potential fees, a day after it delivered lackluster…
Its revenue falling, Dazhong Dental looks to M&A to brighten its outlook
The company has filed to list in Hong Kong, aiming to jumpstart its falling revenue and profits by buying up rivals in China’s fragmented dental services market Key Takeaways: Dazhong…
Sinotau aims to become Hong Kong’s ‘first nuclear-medicine stock’
The company is China’s first to obtain approval for its innovative radiopharmaceuticals Key Takeaways: Sinotau has filed to list in Hong Kong, offering up two commercialized products and a net…
Recent Articles
RELATED ARTICLES
-
Saint Bella births Hong Kong IPO, in race to nurture a postpartum empire
-
BGM transformed by rapid series of AI acquisitions
BGM.US
- Uni-Star under fire as its hit games enter twilight phase
-
BRIEF: Meituan to enter Brazil with $1 billion investment over five years
3690.HK
- Sainte Nutritional nurtures Hong Kong IPO
-
Inmagene Bio charts backdoor to U.S. listing with offshore acquisition
IKNA.US
-
Ruanyun soars as China edtechs learn to live in new environment
RYET.US
